Emerging clinical and research approaches in targeted therapies for high-risk neuroblastoma
Authors:
Open Access
- 4 March 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1553511
Abstract
Neuroblastoma is a pediatric cancer that originates from neural crest cells and is the most common extracranial solid tumor in children under five years of age. While low-risk neuroblastoma often regresses spontaneously, high-risk neuroblastoma poses a significant clinical challenge. Recent advances in understanding neuroblastoma’s molecular mechanisms have led to the development of targeted therapies that aim to selectively inhibit specific pathways involved in tumor growth and progression, improving patient outcomes while minimizing side effects. This review provides a comprehensive review of neuroblastoma biology and emerging therapeutic strategies. Key topics include (a) immunotherapies and immunotargets, (b) non-coding RNAs (long non-coding RNA, microRNA, and circular RNA), (c) molecular biomarkers and pathways, and (d) limitations and future directions.Keywords
Funding Information
- National Cancer Institute (R00CA263016, P30CA093373)
- Hartwell Foundation (A24-2412)
This publication has 169 references indexed in Scilit:
- Molecular targeting therapies for neuroblastoma: Progress and challengesMedicinal Research Reviews, 2020
- CD276 as a novel CAR NK‐92 therapeutic target for neuroblastomaAdvances in Cell and Gene Therapy, 2020
- Combined Replenishment of miR‐34a and let‐7b by Targeted Nanoparticles Inhibits Tumor Growth in Neuroblastoma Preclinical ModelsSmall, 2020
- Role of the extent of prophylactic regional lymph node radiotherapy on survival in high‐risk neuroblastoma: A report from the COG A3973 studyPediatric Blood & Cancer, 2019
- Bioimaging of transcriptional activity of microRNA124a during neurogenesisBiotechnology Letters, 2015
- Sonic Hedgehog pathway is essential for neuroblastoma cell proliferation and tumor growthMolecular and Cellular Biochemistry, 2012
- Notch pathway activation induces neuroblastoma tumor cell growth arrestPediatric Blood & Cancer, 2011
- Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumorsCancer, 2001
- Tumour karyotype may be important in the prognosis of human neuroblastomaJournal of Cancer Research and Clinical Oncology, 1986
- A proposed staging for children with neuroblastoma.Children's cancer study group ACancer, 1971